Setareh Seyedkazemi, Chief Development Officer at Adverum Biotechnologies, Inc. (ADVM), sold 6,201 shares at $1.52 ($9K) on 2023-09-15, disclosed to the SEC on 2023-09-18.
Open-market sale of $9k ADVM by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.52 | 6,071 | $9K | 97.9% |
| 2 | $1.55 | 130 | $202 | 2.1% |
| Total | $1.52 avg | 6,201 | $9K | 100% |
| Filing → |
| ADVM | BUY | 2022-05-24 | $17K | — | Filing → |